Key Finding
A review of complementary and integrative medicine in pancreatic cancer found that acupuncture, alongside nutrition, mind-body therapies, and lifestyle interventions, may meaningfully reduce both physical and psychological symptom burden — including pain, fatigue, and anxiety — across all stages of the disease.
A diagnosis of pancreatic cancer is one of the most challenging a patient can receive. Beyond the disease itself, people living with pancreatic cancer often cope with a heavy burden of symptoms — including anxiety, depression, fatigue, abdominal pain, and nerve-related discomfort — that can seriously affect quality of life and make it harder to stay on track with conventional treatment.
A new review published in Current Oncology Reports looked at how complementary and integrative medicine (CIM) therapies might help. Researchers examined the available evidence on a wide range of approaches — from nutrition counseling and digestive enzyme therapy to physical activity, mindfulness, yoga, massage, reflexology, and acupuncture — to see how well they supported patients at every stage of pancreatic cancer.
The findings are encouraging. Acupuncture, along with other mind-body and lifestyle therapies, showed promise in reducing both physical and psychological symptoms, including pain, fatigue, and emotional distress. Nutritional support, microbiome care, and dietary supplements also appeared to help ease the symptom burden and improve overall wellbeing. Importantly, the review suggests these therapies work best not as replacements for conventional care, but as supportive additions to it.
For patients, this means there may be meaningful, evidence-informed options available to help manage the side effects of treatment and improve day-to-day quality of life — even when a cure is not possible. Integrative approaches like acupuncture can address the whole person, not just the tumor, offering comfort and a sense of agency during a profoundly difficult time.
If you or a loved one is navigating a pancreatic cancer diagnosis, consider speaking with a licensed acupuncturist who has experience working with oncology patients as part of your broader care team.
This narrative review in Current Oncology Reports evaluates the evidence base for complementary and integrative medicine (CIM) modalities in pancreatic ductal adenocarcinoma (PDAC) and broader pancreatic cancer management. Given PDAC's poor prognosis and limited conventional treatment efficacy, the authors systematically assessed CIM interventions across physical, psychological, and supportive care domains. Modalities reviewed include acupuncture, mindfulness-based interventions, yoga, reflexology, massage, homeopathy, nutrition counseling, digestive enzyme therapy, microbiome support, dietary supplementation, physical activity, and circadian/sleep hygiene interventions. The review found accumulating evidence that these modalities collectively reduce symptom burden — particularly pain, fatigue, peripheral neuropathy, anxiety, and depression — and may improve quality of life (QoL) across disease stages. Acupuncture was specifically highlighted as contributing to both physical and psychological symptom reduction. No single effect size was reported, reflecting the heterogeneity of included studies. Clinical takeaway: practitioners should consider proactively integrating CIM — especially acupuncture for pain, neuropathy, and psycho-emotional support — into PDAC palliative and supportive care protocols, pending further methodologically rigorous trials.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Traditional Chinese Medicine enhances immune checkpoint inhibitor efficacy and reduces immune-related adverse events by remodeling the tumor microenvironment, modulating gut microbiota, and alleviating ICI-induced colitis and myocarditis.
📌 Acupuncture demonstrated potential benefits for aromatase inhibitor-induced musculoskeletal symptoms, hot flashes, peripheral neuropathy, and fatigue in breast cancer survivors, supporting its integration into collaborative oncology care.
📌 Among 221 terminally ill cancer patients, 87.3% used at least one form of CAM in the past year, primarily for stress and anxiety reduction, yet no significant differences in physical or psychological symptom scores were found between CAM users and non-users.